Drugmakers, insurers, hospitals, pharmacies, medical devices, clinical updates, and healthcare business leaders.
FFF Enterprises says Moderna selected its BioSupply-based eCommerce platform to run Moderna Direct, aiming to streamline ordering and add self-service features for the biotech’s direct business customers.
THE APEX TIMES
THE APEX TIMES
A syndicated June 4, 2026 market note pegged CVS Health’s brokerage “average recommendation” at a buy-equivalent level, led by strong-buy ratings from most firms surveyed. The same note cautioned that the metric alone is not a reliable guide to where the stock could go.
THE APEX TIMES
The healthcare giant was among a group of top-scoring firms cited by Newsweek and Plant-A Insights Group as part of a new environmental sustainability ranking released June 4.
THE APEX TIMES
A Zacks Rank upgrade to #2 (Buy) on June 4, 2026 highlighted rising optimism around CVS Health’s earnings trajectory, coming shortly after the company raised its 2026 guidance in its first-quarter results.
THE APEX TIMES
At the 2026 ASCO Annual Meeting, the company is highlighting late-stage clinical programs across prostate cancer and multiple myeloma, while separately touting new FcRn-blocker results for systemic lupus and continued momentum in Sjögren’s.
THE APEX TIMES
JNJ closed at $228.17 on June 4, 2026, up 2.21% as a recent market wrap characterized the move as outperforming the broader market. The next major company update is scheduled for mid-July.
THE APEX TIMES
After its Covid-era vaccine surge, Moderna is again positioning its platform for future outbreaks, with a market report highlighting progress in Ebola vaccine development.
THE APEX TIMES
The insurer’s quarterly cash dividend rises from $2.21 to $2.32, payable June 23 to shareholders of record June 15, continuing a long-running payout schedule.
THE APEX TIMES
Moderna’s stock rose in the afternoon after the company and Merck presented long-term results for intismeran autogene, a personalized mRNA-based cancer vaccine, in high-risk melanoma.
